Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Physical & Chemical properties

Particle size distribution (Granulometry)

Currently viewing:

Administrative data

Link to relevant study record(s)

Referenceopen allclose all

Endpoint:
particle size distribution (granulometry)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Information provided by a producer of disilver oxide powder.
Principles of method if other than guideline:
Various established methods/equipment for particle size distribution measurements were used, e.g. a Mastersizer 2000 or CILAS 1180.
GLP compliance:
no
Type of method:
other: Various established methods/equipment for particle size distribution measurements were used, e.g. a Mastersizer 2000 or CILAS 1180.
Type of distribution:
volumetric distribution
Percentile:
D50
Remarks on result:
other: Migrated from fields under 'Mass median diameter' as D50 percentile. No source field for Standard deviation.
Percentile:
D10
Mean:
ca. 2.2 µm
St. dev.:
0
Remarks on result:
other: Representative sample Batch PMC1
Percentile:
D50
Mean:
ca. 3.9 µm
St. dev.:
0
Remarks on result:
other: Representative sample Batch PMC1
Percentile:
D90
Mean:
ca. 6.8 µm
St. dev.:
0
Remarks on result:
other: Representative sample Batch PMC1
Endpoint:
particle size distribution (granulometry)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Information provided by a producer of silver metal powder.
Principles of method if other than guideline:
Various established methods/equipment for particle size distribution measurements were used, e.g. a Mastersizer 2000 or CILAS 1180.
GLP compliance:
no
Type of method:
other: Various established methods/equipment for particle size distribution measurements were used, e.g. a Mastersizer 2000 or CILAS 1180.
Type of distribution:
volumetric distribution
Percentile:
D50
Remarks on result:
other: Migrated from fields under 'Mass median diameter' as D50 percentile. No source field for Standard deviation.
Percentile:
D10
Mean:
> 2 - < 8 µm
St. dev.:
0
Remarks on result:
other: Representative sample Batch PMC2
Percentile:
D50
Mean:
> 7 - < 18 µm
St. dev.:
0
Remarks on result:
other: Representative sample Batch PMC2
Percentile:
D90
Mean:
> 16 - < 31 µm
St. dev.:
0
Remarks on result:
other: Representative sample Batch PMC2
Endpoint:
particle size distribution (granulometry)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods with acceptable restrictions
Remarks:
Test procedure in accordance with national standards DIN 55992-1:2006 ("Determination of a parameter for the dust formation of pigments and extenders - Part 1: Rotation method"), modified Heubach method no data for: - Analytical purity - Purity test date: - Expiration date of the batch:
Qualifier:
according to guideline
Guideline:
other: DIN 55992-1:2006 (Determination of a parameter for the dust formation of pigments and extenders – Part 1: Rotation method)
Deviations:
yes
Remarks:
The Heubach dust meter is modified in a way that a seven stage cascade impactor is connected to the system. See also field on "Principle of method if other than guideline".
Principles of method if other than guideline:
The Heubach dust meter is modified in a way that a seven stage cascade impactor is connected to the system. This involves an additional air fed of 20 L/min via the coarse dust separator needed to supply the cascade impactor with 40 L/min air current as specified in the manufacturer’s specificcations.
The calculation report: EBRC (2010)
The Multiple-Path Particle Dosimetry Model (MPPD, v2.0; CIIT, 2006) was used to predict this fractional deposition behaviour for workers.
The model algorithms calculate the deposition (and clearance) of mono-disperse and polydisperse aerosols in the respiratory tract for particles ranging from ultra-fine (0.01 microns) to coarse (20 microns) sizes. Within each airway, deposition is calculated using theoretically derived efficiencies for deposition by diffusion, sedimentation and impaction within the airway or airway bifurcation. Filtration of aerosols by the head is determined using empirical efficiency functions (for further information see "attached background material").
GLP compliance:
no
Type of method:
cascade impaction
Remarks:
For more details, please see section "Principles of method if other than guideline"
Type of distribution:
volumetric distribution
Percentile:
D50
Remarks on result:
other: Migrated from fields under 'Mass median diameter' as D50 percentile. No source field for Standard deviation.

Dustiness (airborne fraction): total: 126.14 mg/g.

In the original study report by DMT, a calculation of the mass median diameter was not conducted. Since the deposited fractions were provided for each of the cascade impactor stages, it was possible to fit a mono modal lognormal distribution to the data by standard non-linear regression procedure. As a result, the MMAD and GSD are calculable and reported (MMAD = 27.0 µm, GSD = 3.3). As the cascade impactor already takes aerodynamic characteristics of the particles into account, the reported mass median diameter can be interpreted as the mass medianaerodynamicdiameter.

This figure and the corresponding GSD were used as distribution parameters for the MPPD model enabling an estimation of deposited dust fractions in the human respiratory tract: These fractions were estimated as follows:

Head (ET): 47.9%

Tracheobronchial (TB): 0.5%

Pulmonary (PU): 0.8%

Conclusions:
Disilver oxide - Batch PMC 2

Total Dustiness (airborne fraction): 126.14 mg/g (experimental results, DMT Report).

Mass median aerodynamic diamater of airborne fraction: MMAD = 27.0 µm (distribution fitted to cascade impactor data).
Geometric standard deviation of MMAD: GSD = 3.3

Fractional deposition in human respiratory tract (MPPD model, based on calculated MMAD):
Head (ET): 47.9%
Tracheobronchial (TB): 0.5%
Pulmonary (PU): 0.8%
Endpoint:
particle size distribution (granulometry)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods with acceptable restrictions
Remarks:
Test procedure in accordance with national standards DIN 55992-1:2006 ("Determination of a parameter for the dust formation of pigments and extenders - Part 1: Rotation method"), modified Heubach method no data for: - Analytical purity - Purity test date: - Expiration date of the batch:
Qualifier:
according to guideline
Guideline:
other: DIN 55992-1:2006 (Determination of a parameter for the dust formation of pigments and extenders – Part 1: Rotation method)
Deviations:
yes
Remarks:
The Heubach dust meter is modified in a way that a seven stage cascade impactor is connected to the system. See also field on "Principle of method if other than guideline".
Principles of method if other than guideline:
The Heubach dust meter is modified in a way that a seven stage cascade impactor is connected to the system. This involves an additional air fed of 20 L/min via the coarse dust separator needed to supply the cascade impactor with 40 L/min air current as specified in the manufacturer’s specificcations.
The calculation report: EBRC (2010)
The Multiple-Path Particle Dosimetry Model (MPPD, v2.0; CIIT, 2006) was used to predict this fractional deposition behaviour for workers.
The model algorithms calculate the deposition (and clearance) of mono-disperse and polydisperse aerosols in the respiratory tract for particles ranging from ultra-fine (0.01 microns) to coarse (20 microns) sizes. Within each airway, deposition is calculated using theoretically derived efficiencies for deposition by diffusion, sedimentation and impaction within the airway or airway bifurcation. Filtration of aerosols by the head is determined using empirical efficiency functions (for further information see "attached background material").
GLP compliance:
no
Type of method:
cascade impaction
Remarks:
for more details, please see section "Principles of method if other than guideline"
Type of distribution:
volumetric distribution
Percentile:
D50
Remarks on result:
other: Migrated from fields under 'Mass median diameter' as D50 percentile. No source field for Standard deviation.

Dustiness (airborne fraction): total: 148.83 mg/g.

In the original study report by DMT, a calculation of the mass median diameter was not conducted. Since the deposited fractions were provided for each of the cascade impactor stages, it was possible to fit a mono modal lognormal distribution to the data by standard non-linear regression procedure. As a result, the MMAD and GSD are calculable and reported (MMAD = 32.5µm, GSD = 2.9). As the cascade impactor already takes aerodynamic characteristics of the particles into account, the reported mass median diameter can be interpreted as the mass medianaerodynamicdiameter.

This figure and the corresponding GSD were used as distribution parameters for the MPPD model enabling an estimation of deposited dust fractions in the human respiratory tract: These fractions were estimated as follows:

Head (ET): 45.3%

Tracheobronchial (TB): 0.3%

Pulmonary (PU): 0.6%

Conclusions:
Disilver oxide - Batch PMC 1

Total Dustiness (airborne fraction): 148.83 mg/g (experimental results, DMT Report).

Mass median aerodynamic diamater of airborne fraction: MMAD = 32.5 µm (distribution fitted to cascade impactor data).
Geometric standard deviation of MMAD: GSD = 2.9

Fractional deposition in human respiratory tract (MPPD model, based on calculated MMAD):
Head (ET): 45.3%
Tracheobronchial (TB): 0.3%
Pulmonary (PU): 0.6%

Description of key information

Additional information

The particle size parameters for the two representative sample of disilver oxide powders are presented in the following format: D10,D50,D90 of the material; MMAD of airborne dust (GSD):


Batch PMC 1: 2.2µm, 3.9µm, 6.8µm; 32.5µm (2.9)


Batch PMC 2: 2 -8µm, 7 -18µm,16 -31µm; 27µm (3.3)


In addition, disilver oxide is produced and marketed in powder form. Powders are produced with variable specifications, including various particle size distributions. Member companies of the precious metals consortium have provided two representative samples of commercial disilver oxide powders (Batches PMC 1-2) and provided particle size information data. In addition to these specifications provided by the producers, experimental investigations on the dustiness (rotating drum method) and on the particles size distribution of material that becomes airborne during such tests have been performed.